QT Vascular kept at 'buy' with 60 cents target price by UOB Kay Hian

Stock Name: QT Vascular
Company Name: QT VASCULAR LTD.

Research House: UOB KayHian

Price Call: BUY

Target Price: 0.60

SINGAPORE (Feb 26): UOB Kay Hian has maintained its "buy" rating for QT Vascular, the designer and distributor of medical devices for vascular diseases, with a target price of 60 cents, as its FY14 results came in within expectations.

FY14 revenue rose 140.7% yoy to US$13.2 million ($17.9 million), compared with UOB Kay Hian estimates of US$13.4 million, driven by higher sales volumes of the Chocolate PTA and Glider PTCA balloon catheters in the US.

QT Vascular kept at 'add' with 73 cents target price by CIMB

Stock Name: QT Vascular
Company Name: QT VASCULAR LTD.

Research House: CIMB

Price Call: BUY

Target Price: 0.73

SINGAPORE (Nov 19): CIMB Research has reiterated its "add" call on CIMB with a 73 cents price target.

In a Nov 18 note, analyst Gary Ng says QT Vasular's rollout of coronary Chocolate balloon catheters in the US and EU and shipments of Glider balloon catheters to Japan and China in late-4Q14 as well as various regulatory approvals for products next year are positive share price catalysts.